Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Chemotherapy. Found 29 abstracts

no pagination
Bamias A, Tzannis K, Bamia C, Harshman LC, Crabb S, Plimack ER, Pal S, De Giorgi U, Ladoire S, Theodore C, Agarwal N, Yu EY, Niegisch G, Sternberg CN, Srinivas S, Vaishampayan U, Necchi A, Liontos M, Rosenberg JE, Powles T, Bellmunt J, Galsky MD. The Impact of Cisplatin- or Non-Cisplatin-Containing Chemotherapy on Long-Term and Conditional Survival of Patients with Advanced Urinary Tract Cancer. The oncologist. 2019 Oct;24(10):1348-55.   PMCID: PMC6795165
Abbosh P, Sundararajan S, Millis SZ, Hauben A, Reddy S, Geynisman DM, Uzzo R. Molecular and Genomic Profiling to Identify Actionable Targets in Chromophobe Renal Cell Cancer. European urology focus. 2018 Dec;4(6):969-71.
Feliciano JL, Le-Rademacher JG, Gajra A, Edelman MJ, Zemla T, McMurray R, Chen H, Hurria A, Muss H, Cohen HJ, Lilenbaum R, Jatoi A. Do older patients with non-small cell lung cancer also benefit from first-line platinum-based doublet chemotherapy? Observations from a pooled analysis of 730 prospectively-treated patients (Alliance Study A151622). Journal of geriatric oncology. 2018 Sep;9(5):501-6.   PMCID: PMC6233872
Godwin JL, Hoffman-Censits J, Plimack E. Recent developments in the treatment of advanced bladder cancer. Urol Oncol. 2018 Mar;36(3):109-14.   PMCID: Review
Wahab A, Kesari K, J Smith S, Liu Y, Barta SK. Type B lactic acidosis, an uncommon paraneoplastic syndrome. Cancer Biol Ther. 2018 Feb;19(2):101-4.   PMCID: PMC5790396
Wong YN, Manola J, Hudes GR, Roth BJ, Moul JW, Barsevick AM, Scher RM, Volk MJ, Vaughn DJ, Williams SD, Fisch MJ, Cella D, Carducci MA, Wilding G. Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: ECOG-ACRIN Cancer Research Group (E1898) Trial. Clin Genitourin Cancer. 2018 Apr;16(2):e315-e322.   PMCID: PMC5975965
Chera B, Wang K, Monroe A, Galloway T, Amdur R, Hayes DN, Zevallos J, Mendenhall WM. Truth or myth: Definitive chemoradiotherapy doesn't work for HPV/p16 negative oropharyngeal squamous cell carcinoma?. Oral Oncol. 2017 Feb;65:125-6.
Cornell RF, D'Souza A, Kassim AA, Costa LJ, Innis-Shelton RD, Zhang MJ, Huang J, Abidi M, Aiello J, Akpek G, Bashey A, Bashir Q, Cerny J, Comenzo R, Diaz MA, Freytes C, Gale RP, Ganguly S, Hamadani M, Hashmi S, Holmberg L, Hossain N, Kamble RT, Kharfan-Dabaja M, Kindwall-Keller T, Kyle R, Kumar S, Lazarus H, Lee C, Maiolino A, Marks DI, Meehan K, Mikhael J, Nath R, Nishihori T, Olsson RF, Ramanathan M, Saad A, Seo S, Usmani S, Vesole D, Vij R, Vogl D, Wirk BM, Yared J, Krishnan A, Mark T, Nieto Y, Hari P. Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma. Biol Blood Marrow Transplant. 2017 Feb;23(2):269-77.   PMCID: PMC5346183
Goel N, Reddy SS. Randomized Clinical Trials in Pancreatic Cancer. Surg Oncol Clin N Am. 2017 Oct;26(4):767-90.   PMCID: Review
Bayne CE, Williams SB, Cooperberg MR, Gleave ME, Graefen M, Montorsi F, Novara G, Smaldone MC, Sooriakumaran P, Wiklund PN, Chapin BF. Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives. Eur Urol. 2016 May 20;69(5):775-87.
Ma C, Wang B, Cvetkovic D, Chen L. SU-F-J-216: MR-Guided Non-Thermal Pulsed Focused Ultrasound for Cancer Therapy. Med Phys. 2016 Jun;43(6):3458.
Ma C, Wang B, Cvetkovic D, Chen L. SU-F-J-216: MR-Guided Non-Thermal Pulsed Focused Ultrasound for Cancer Therapy. Med Phys. 2016 Jun;43(6):3458.
Porpiglia AS, Reddy SS, Farma JM. Retroperitoneal Sarcomas. Surg Clin North Am. 2016 Oct;96(5):993-1001.
Sheng JY, Movva S. Systemic Therapy for Advanced Soft Tissue Sarcoma. Surg Clin North Am. 2016 Oct;96(5):1141-56.
Abbosh PH, McConkey DJ, Plimack ER. Targeting Signaling Transduction Pathways in Bladder Cancer. Current oncology reports. 2015 Dec;17(12):58.
Ream E, Gargaro G, Barsevick A, Richardson A. Management of cancer-related fatigue during chemotherapy through telephone motivational interviewing: Modeling and randomized exploratory trial. Patient education and counseling. 2015 Feb;98(2):199-206.
Vijayvergia N, Dotan E, Devarajan K, Hatahet K, Rahman F, Ricco J, Lewis B, Gupta S, Cohen SJ. Patterns of care and outcomes of older versus younger patients with metastatic pancreatic cancer: A Fox Chase Cancer Center experience. Journal of geriatric oncology. 2015 Aug 18;6(6):454-61.   PMCID: 4921214
Singla S, Papavasiliou P, Powers B, Gaughan J, von Mehren M, Watson JC, Farma JM. Challenges in the treatment of angiosarcoma: a single institution experience. Am J Surg. 2014 Aug;208(2):254-9.
Swisher SG, Winter KA, Komaki RU, Ajani JA, Wu TT, Hofstetter WL, Konski AA, Willett CG. A PHASE II STUDY OF A PACLITAXEL-BASED CHEMORADIATION REGIMEN WITH SELECTIVE SURGICAL SALVAGE FOR RESECTABLE LOCOREGIONALLY ADVANCED ESOPHAGEAL CANCER: INITIAL REPORTING OF RTOG 0246. International Journal of Radiation Oncology Biology Physics. 2012 Apr;82(5):1967-72.   PMCID: *
Wong SJ, Winter K, Meropol NJ, Anne PR, Kachnic L, Rashid A, Watson JC, Mitchell E, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG. RADIATION THERAPY ONCOLOGY GROUP 0247: A RANDOMIZED PHASE II STUDY OF NEOADJUVANT CAPECITABINE AND IRINOTECAN OR CAPECITABINE AND OXALIPLATIN WITH CONCURRENT RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER. International Journal of Radiation Oncology Biology Physics. 2012 Mar;82(4):1367-75.   PMCID: PMC3208721
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Chemotherapy

Chemotherapy Cancer Radiation radiotherapy Ultrasound therapy Clinical trials Biomedical modeling Magnetic resonance imaging Surgery Ultrasonography chemoradiotherapy Germanium chemotherapy Survival Chemoradiation Image scanners Comparative animal models Bladder cancer Hpv Lactic acidosis i Combined Modality Therapy Leukocytosis Telephone intervention Myeloma Lactic acid Head and Neck Neoplasms Male Randomized control trails Relapse Female randomized-trial Kaplan-Meier Estimate ii Prostate cancer Geriatric oncology Mutation Older adults Sunitinib Older patients Urothelial carcinoma Fatigue Adult Rectal Targeted therapy preoperative radiotherapy Middle Aged Metastases surgery Salvage surgery Advanced soft tissue sarcoma Oropharynx 80 and over Aged Molecular profiling Retroperitoneal liposarcoma Breast Neoplasms Castration resistant Immunophenotyping mortality Lung cancer Pik3ca Metastatic pancreatic cancer Conditional survival Maintenance Transplantation Everolimus Prostatectomy Pazopanib Young Adult Hemangiosarcoma Bone Marrow Biopsy dose radiation Erbb3 Erbb2 Bevacizumab Radiotherapy Radiation therapy Novel therapies article Mantle Cell Lymphoma Prognosis Copy number abnormality Urothelial cancer Pancreatic cancer chemoradiation Long-term survival mTOR Neoplasm metastasis diagnosis Carboplatin Dovitinib fluorouracil Neoadjuvant Psychological intervention Cetuximab Esophageal cancer Egfr Retroperitoneal sarcoma Immunotherapy pathological complete response Fgfr3 Aged Erlotinib drug therapy Checkpoint inhibitors trial Angiosarcoma Pten Randomized trials Motivational interviewing Prostatic neoplasms infusion Platinum ineligible Chromophobe renal carcinoma Genetics squamous-cell carcinoma
Last updated on Friday, December 06, 2019